A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer
Abstract Background Although clinical trials have investigated the addition of pembrolizumab to chemotherapy for non‐small cell lung cancer, none have investigated the addition of chemotherapy to pembrolizumab. Methods We conducted a retrospective study of 71 NSCLC patients including 33 treated with...
Main Authors: | Taisuke Isono, Naho Kagiyama, Shun Shibata, Hitomi Nakajima, Yuma Matsui, Kenji Takano, Takashi Nishida, Chiaki Hosoda, Eriko Kawate, Yoichi Kobayashi, Takashi Ishiguro, Yotaro Takaku, Kazuyoshi Kurashima, Tsutomu Yanagisawa, Noboru Takayanagi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13915 |
Similar Items
-
Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia
by: Takashi Ishiguro, et al.
Published: (2020-01-01) -
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
by: Hao‐Chun Chang, et al.
Published: (2020-08-01) -
Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis.
by: Aya Wakabayashi, et al.
Published: (2018-01-01) -
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
by: Bernard F. Hearon, et al.
Published: (2020-12-01) -
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
by: Eisuke Kato, et al.
Published: (2018-02-01)